Stay updated with breaking news from Operations Data. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Company is poised to commence Phase 3 for RZ358 in the third quarter of calendar year 2023REDWOOD CITY, Calif., May 11, 2023 -- Rezolute, Inc. , a clinical-stage biopharmaceutical company... | May 11, 2023
Presented positive interim data from intravitreal 4D-150 Phase 1/2 PRISM clinical trial for wet age-related macular degeneration at the 2023 ARVO Annual MeetingOn track for completion of enrollment... | May 10, 2023
Turkcell Iletisim Hizmetleri A.S. (NYSE:TKC) (BIST:TCELL): Please note that all financial data is consolidated and comprises that of Turkcell Iletisim Hizmetleri A.S. (the "Company", or "Turkcell")
08.05.2023 - ─ Tuspetinib Dose Escalation and Dose Exploration Trial Completed and Delivered Clinical Responses as Monotherapy Over Four Dose Levels in Very Difficult to Treat AML Patient Populations ─ ─ Doublet of Tuspetinib and Venetoclax Dosing Underway for ...
BASIS OF PRESENTATION This Management's Discussion and Analysis for Westport Fuel Systems Inc. for the three months ended March 31, 2023 provides an update to our annual... | May 8, 2023